153 related articles for article (PubMed ID: 26669325)
1. Correspondence regarding: Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome by Bhatt et al.
O'Rourke MF; Adji A; Weber T
Vasc Med; 2016 Feb; 21(1):70. PubMed ID: 26669325
[No Abstract] [Full Text] [Related]
2. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
Bhatt AB; Buck JS; Zuflacht JP; Milian J; Kadivar S; Gauvreau K; Singh MN; Creager MA
Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
[TBL] [Abstract][Full Text] [Related]
3. Atenolol versus Losartan in Marfan's Syndrome.
Mallat Z; Tedgui A
N Engl J Med; 2015 Mar; 372(10):980. PubMed ID: 25738683
[No Abstract] [Full Text] [Related]
4. Atenolol versus Losartan in Marfan's Syndrome.
Treasure T; Pepper J; Mohiaddin R
N Engl J Med; 2015 Mar; 372(10):978-9. PubMed ID: 25738682
[No Abstract] [Full Text] [Related]
5. Atenolol versus Losartan in Marfan's Syndrome.
Ziganshin BA; Mukherjee SK; Elefteriades JA
N Engl J Med; 2015 Mar; 372(10):977-8. PubMed ID: 25738681
[No Abstract] [Full Text] [Related]
6. Atenolol versus Losartan in Marfan's Syndrome.
Lacro RV; Dietz HC; Mahony L
N Engl J Med; 2015 Mar; 372(10):980-1. PubMed ID: 25738680
[No Abstract] [Full Text] [Related]
7. Of Marfan's syndrome, mice, and medications.
Bowen JM; Connolly HM
N Engl J Med; 2014 Nov; 371(22):2127-8. PubMed ID: 25405389
[No Abstract] [Full Text] [Related]
8. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
Teixido-Tura G; Forteza A; Rodríguez-Palomares J; González Mirelis J; Gutiérrez L; Sánchez V; Ibáñez B; García-Dorado D; Evangelista A
J Am Coll Cardiol; 2018 Oct; 72(14):1613-1618. PubMed ID: 30261963
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
[TBL] [Abstract][Full Text] [Related]
10. [Drugs news].
Lengellé C; Bejan-Angoulvant T; Beau-Salinas F; Jonville-Béra AP
Arch Pediatr; 2015 Nov; 22(11):1200-6. PubMed ID: 26385645
[No Abstract] [Full Text] [Related]
11. Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.
Van Driest SL; Sleeper LA; Gelb BD; Morris SA; Dietz HC; Forbus GA; Goldmuntz E; Hoskoppal A; James J; Lee TM; Levine JC; Li JS; Loeys BL; Markham LW; Meester JAN; Mital S; Mosley JD; Olson AK; Renard M; Shaffer CM; Sharkey A; Young L; Lacro RV; Roden DM
J Pediatr; 2020 Jul; 222():213-220.e5. PubMed ID: 32586526
[TBL] [Abstract][Full Text] [Related]
12. Atenolol versus losartan in children and young adults with Marfan's syndrome.
Lacro RV; Dietz HC; Sleeper LA; Yetman AT; Bradley TJ; Colan SD; Pearson GD; Selamet Tierney ES; Levine JC; Atz AM; Benson DW; Braverman AC; Chen S; De Backer J; Gelb BD; Grossfeld PD; Klein GL; Lai WW; Liou A; Loeys BL; Markham LW; Olson AK; Paridon SM; Pemberton VL; Pierpont ME; Pyeritz RE; Radojewski E; Roman MJ; Sharkey AM; Stylianou MP; Wechsler SB; Young LT; Mahony L;
N Engl J Med; 2014 Nov; 371(22):2061-71. PubMed ID: 25405392
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.
Forteza A; Evangelista A; Sánchez V; Teixidó-Turà G; Sanz P; Gutiérrez L; Gracia T; Centeno J; Rodríguez-Palomares J; Rufilanchas JJ; Cortina J; Ferreira-González I; García-Dorado D
Eur Heart J; 2016 Mar; 37(12):978-85. PubMed ID: 26518245
[TBL] [Abstract][Full Text] [Related]
14. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.
Lacro RV; Guey LT; Dietz HC; Pearson GD; Yetman AT; Gelb BD; Loeys BL; Benson DW; Bradley TJ; De Backer J; Forbus GA; Klein GL; Lai WW; Levine JC; Lewin MB; Markham LW; Paridon SM; Pierpont ME; Radojewski E; Selamet Tierney ES; Sharkey AM; Wechsler SB; Mahony L;
Am Heart J; 2013 May; 165(5):828-835.e3. PubMed ID: 23622922
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.
Lacro RV; Dietz HC; Wruck LM; Bradley TJ; Colan SD; Devereux RB; Klein GL; Li JS; Minich LL; Paridon SM; Pearson GD; Printz BF; Pyeritz RE; Radojewski E; Roman MJ; Saul JP; Stylianou MP; Mahony L;
Am Heart J; 2007 Oct; 154(4):624-31. PubMed ID: 17892982
[TBL] [Abstract][Full Text] [Related]
17. Role of losartan in prevention of aortic dilatation in Marfan syndrome: A systematic review and meta-analysis.
Li L; Yamani N; Al-Naimat S; Khurshid A; Usman MS
Eur J Prev Cardiol; 2020 Sep; 27(13):1447-1450. PubMed ID: 31260329
[No Abstract] [Full Text] [Related]
18. Medicine. Old drug, new hope for Marfan syndrome.
Travis J
Science; 2006 Apr; 312(5770):36-7. PubMed ID: 16601163
[No Abstract] [Full Text] [Related]
19. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial.
Radonic T; de Witte P; Baars MJ; Zwinderman AH; Mulder BJ; Groenink M;
Trials; 2010 Jan; 11():3. PubMed ID: 20067609
[TBL] [Abstract][Full Text] [Related]
20. Marfan Syndrome (MFS): Visual Diagnosis and Early Identification.
Temples HS; Rogers CR; Willoughby D; Holaday B
J Pediatr Health Care; 2017; 31(5):609-617. PubMed ID: 28666770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
